Posted on 11/26/18
Ambra Health and Google Cloud Collaborate
Ambra Health, makers of a leading cloud-based, medical image management suite, today announced a new collaboration with Google Cloud to advance healthcare research with anonymized medical . . .
Posted on 11/26/18
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to ReviveMed, Strand Therapeutics
PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, . . .
Posted on 11/26/18
Clover Health Partners with HealthHelp
NEW YORK & MUMBAI, India--(BUSINESS WIRE)--Clover Health, a healthcare company using technology to improve medical outcomes, today announced a new partnership with collaborative care management leader, . . .
Posted on 11/26/18
Rocket Pharmaceuticals and REGENXBIO Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector
NEW YORK & ROCKVILLE, Md.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (Nasdaq:RCKT), a leading U.S.-based multi-platform gene therapy company, and REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking . . .
Posted on 11/26/18
Edge Therapeutics and PDS Biotechnology To Merge
Edge Therapeutics, Inc. (Nasdaq: EDGE) and PDS Biotechnology Corporation, a privately-held, clinical-stage cancer immunotherapy company, announced today that their respective boards
Posted on 11/26/18
Better Buy: Pfizer vs. Bristol-Myers Squibb
Frenemies might be one of those annoying word mash-ups, but the term definitely describes the relationship between two of the biggest drugmakers on the planet: Pfizer . . .
Posted on 11/21/18
Celgene's Positives Greatly Outweigh Negatives
SummaryCelgene had some bad news, driving the stock to bargain prices in 2018.Ozanimod and Fedratinib applications to the FDA will be good signs.Multiple sales generators are . . .
Posted on 11/21/18
Aquestive Provides Business Update Following Suboxone Patent Ruling
Aquestive Therapeutics today received news that The U.S. Court of Appeals for the Federal Circuit overturned the preliminary injunction against Dr. Reddy's Laboratories ("DRL") as it . . .
Posted on 11/20/18
Hudson Headwaters Joins Aetna’s New York Network In Adirondack, North Country And Glens Falls Region
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Hudson Headwaters Health Network and Aetna (NYSE: AET) announced today a new agreement adding Hudson Headwaters’ system of 17 community health centers in the . . .
Posted on 11/20/18
Cambrex To Acquire Avista Pharma Solutions For $252M
Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms
Posted on 11/20/18
Is Johnson & Johnson A Buy Here?
SummaryJohnson & Johnson is a Dividend King that recently raised their dividend for the 56th consecutive year.Packed with a well diversified portfolio, JNJ can thrive in . . .
Posted on 11/19/18
Better Buy: Celgene Corporation vs. Merck & Co.
Two drug stocks diverged in a yellow wood. And sorry I could not buy both and be one investor, long I stood.My apologies to Robert Frost . . .
Posted on 11/19/18
Where Will Pfizer Inc. Be in 5 Years?
With a little momentum at the end of 2018, Pfizer Inc. (NYSE:PFE) could be headed for its best year yet in the 21st century. The big . . .
Posted on 11/19/18
Better Buy: Abbott Laboratories vs. Johnson & Johnson
When you think about blue chip stocks in healthcare, which stocks come to mind? For many, Abbott Laboratories (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ) would be . . .
Posted on 11/19/18
Cantel Medical To Acquire Omnia For Europe Expansion
Cantel Medical (CMD) announced it has agreed to acquire Omnia for $31.9 million.
Posted on 11/19/18
Aquestive Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration
Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) in regards to its . . .
Posted on 11/16/18
J&J Snack Foods Has To Pull Back, Right?
SummaryJJSF has risen nicely since the recession, buoyed by ever-expanding multiples.The market even shrugged at a disappointing Q4 that capped off a rather weak fiscal 2018.At . . .
Posted on 11/16/18
Why Johnson & Johnson's Up 3% So Far in 2018
The healthcare industry has done extremely well in 2018, and many companies in the space have posted stellar gains. That makes the lackluster gains that industry . . .
Posted on 11/16/18
Why Pfizer Is Up 19% in 2018 So Far
It's been a banner year for shares of America's largest pharmaceutical company, but you wouldn't know it by looking at Pfizer's (NYSE:PFE) top line in recent . . .
Posted on 11/16/18
Ambra Health Named 2018 Finalist for Fierce Healthcare Innovation Award
Ambra Health, makers of the leading cloud-based, medical image management suite, today announced that Ambra Suite was named as one of three Fierce Health Innovation Award . . .
Posted on 11/15/18
AdminaHealth Partners With Common Census
AdminaHealth LLC, a leading provider of technology and financial solutions for benefits administrators, today announced a technology partnership with Common Census, a provider of software solutions . . .
Posted on 11/15/18
HealthCare.com Ranked Number 92 Fastest Growing Company in North America on Deloitte's 2018 Technology Fast 500
HealthCare.com a leading direct-to-consumer health insurance company, today announced it ranked #92 on Deloitte's Technology Fast 500, a ranking of the 500 fastest growing technology, media, . . .
Posted on 11/15/18
Hengrui Pharma Partners with Medidata
NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) announced that Hengrui Pharma, one of China’s largest sponsors, recently adopted Medidata Cloud, the Intelligent Platform for Life Sciences, to accelerate . . .
Posted on 11/15/18
Medicrea Reports Third-Quarter Results
LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market – MRNTY & MRNTF), pioneering the transformation of spinal surgery . . .
Posted on 11/15/18
Akari Announces Third Quarter 2018 Financial Results and Business Highlights
NEW YORK and LONDON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and . . .

